---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "KYUyIStykzL1ysCPbKGhZfjyVMDz5Gf93KdTtC/H7MhoqGIf6tn5y2vQ1//bG12mvXEkiryNOrzBksCSHUqzfJOQ3YlMkt7y6r/Od5YFivwBI346rlXLzlMXIsQ56C4u0m8LMr9WdLy2NrIfnbzd4DIYMBWUsVL+611mLo78JSJttwn3QeoEeXEghsSo+NzHQBZHGkBOkQJ/M7/Ikc7RAclM5t9LxBKuTzvflQMmemJ8pUQhiS0l6kFTZCTQ1z+qVUxgUCSvA/QokVA5VSa/DP+VT+3PChPCPra6Uzxt7xl5OnK4teDtyvec6kuWyhgC;vbWYSsZFY7xBQhkkCWmaHg=="
---

